Opens in a new tab or window Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients. The American Academy of ...

Among these patients, 76% have hyperphosphatemia, and the rate of achieving target phosphate levels is only 39% 1 (according to China’s hemodialysis quality control standards: serum phosphate 1. ...

ArcticBlast is a topical pain relief solution that targets joint and muscle discomfort through direct application. Unlike oral pain relievers that work systemically, ArcticBlast pain relieving ...

There are plenty of fun experiences to be had in Lost Records: Bloom and Rage as Swann and her friends bond over summer break. Not only do they learn more about each other, but their sleepy town ...

The topical antibiotics clindamycin and erythromycin are indicated for inflammatory acne and work by inhibiting bacterial protein synthesis (Akhavan & Bershad, 2003). Both are available as single ...

This map has a couple of solution hints. The first is the squat building it singles out, and the second is the text’s mention of “stealing from a delemgen.” At the top of the hill is the ...

The “Clindamycin Phosphate Topical Market” report delivers a comprehensive analysis of the industry, providing valuable insights into its SWOT analysis, growth prospects, and anticipated CAGR. It ...

(RTTNews) - India-based Glenmark Pharmaceuticals Inc.'s USA subsidiary, Thursday announced the launch of Clindamycin Phosphate Foam, 1 percent for the treatment of acne. The company added that ...

1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the property of their respective owners.

Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically equivalent to Evoclin® ...